A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
NCT04843215 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 950
Last updated 2021-05-10
Summary
This is a phase III, multicenter, prospective, randomized, controlled clinical trial to evaluate the impact of omentectomy for advanced gastric cancer on patient survival.
Conditions
Interventions
- PROCEDURE
-
Type of omentectomy
Experimental group D2 radical gastrectomy with partial omentectomy. Partial omentectomy with preservation of the greater omentum at \>3 cm from the gastroepiploic arcade.Control group with total omentectomy.
Sponsors & Collaborators
-
Peking University Cancer Hospital & Institute
collaborator OTHER -
Shanghai Zhongshan Hospital
collaborator OTHER -
Fujian Cancer Hospital
collaborator OTHER_GOV -
Fujian Medical University Union Hospital
collaborator OTHER -
First Affiliated Hospital of Guangxi Medical University
collaborator OTHER -
Harbin Medical University
collaborator OTHER -
Hebei Medical University Fourth Hospital
collaborator OTHER -
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
collaborator OTHER -
The First Affiliated Hospital with Nanjing Medical University
collaborator OTHER -
Changzhi People's Hospital
collaborator OTHER -
The First Affiliated Hospital of Air Force Medicial University
collaborator OTHER -
First Affiliated Hospital of Kunming Medical University
collaborator OTHER -
LanZhou University
collaborator OTHER -
Liaoning Cancer Hospital & Institute
collaborator OTHER -
The First Affiliated Hospital of Nanchang University
collaborator OTHER -
Shandong Provincial Hospital
collaborator OTHER_GOV -
West China Hospital
collaborator OTHER -
Xinjiang Medical University Cancer Hospital
collaborator UNKNOWN -
Zhejiang Cancer Hospital
collaborator OTHER -
Chinese PLA General Hospital
collaborator OTHER -
Sun Yat-sen University Cancer Hosptial
collaborator UNKNOWN -
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
collaborator OTHER -
Tianjin Medical University Cancer Institute and Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2023-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis
NCT04440605 ·Status: UNKNOWN
-
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
NCT02845986 ·Status: UNKNOWN ·Phase: PHASE2
-
Robotic Total Gastrectomy for Locally Advanced Proximal Gastric Cancer
NCT03524287 ·Status: COMPLETED ·Phase: NA
-
Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer
NCT03273920 ·Status: UNKNOWN ·Phase: NA
-
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor
NCT03399253 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer
NCT02423278 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer
NCT06791538 ·Status: RECRUITING ·Phase: NA
-
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
NCT05980481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Preoperative Stomach Cancer Induction Chemotherapy and Radiation Therapy
NCT03223740 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer
NCT02327481 ·Status: COMPLETED ·Phase: NA
-
A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.
NCT02648841 ·Status: UNKNOWN ·Phase: PHASE3
-
Spleen-Preserving No. 10 Lymph Node Dissection in Gastric Cancer
NCT04050787 ·Status: UNKNOWN ·Phase: NA
-
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
NCT02873520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant Chemotherapy
NCT02404753 ·Status: UNKNOWN ·Phase: PHASE2
-
Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT03874871 ·Status: UNKNOWN
-
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
NCT05871099 ·Status: RECRUITING ·Phase: PHASE3
-
A Benefit Population Atlas of nICT Versus nCT for LAGC
NCT07098104 ·Status: COMPLETED
-
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer
NCT04850716 ·Status: UNKNOWN
-
Radical Gastrectomy With/Without HIPEC in Advanced Gastric Cancer Patients
NCT02381847 ·Status: UNKNOWN ·Phase: PHASE3
-
Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
NCT06895447 ·Status: RECRUITING ·Phase: PHASE2
-
Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis
NCT03023436 ·Status: UNKNOWN ·Phase: PHASE3
-
Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer
NCT04795063 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.
NCT03001726 ·Status: UNKNOWN
-
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
NCT06277453 ·Status: ACTIVE_NOT_RECRUITING
-
Phase III Study OF the Gastric Surgery on Advanced Stage Gastric Cancer
NCT00260884 ·Status: COMPLETED ·Phase: PHASE3